Navigation Links
Florida Hospital collaborates with VTT of Finland
Date:9/18/2013

ORLANDO, Fla., September 18, 2013 In an effort to better understand the development of Alzheimer's disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.

Scientists from VTT and the University of Eastern Finland recently teamed up to discover a serum biochemical signature which predicts progression to Alzheimer's disease. From this, VTT was able to develop a biomarker assay. Florida Hospital and VTT have since come together to evaluate screening, diagnostic and prognostic potential of the biomarker essay.

"Our commitment as a hospital to researching how Alzheimer's disease begins is extremely important for early detection studies and eventually finding a cure for the disease," said Debbie Spielman, AVP Florida Hospital Neuroscience Institute. "Early disease detection can assist in discovering which pharmacological treatment or lifestyle changes would be most beneficial for the patient approaching the early stages of Alzheimer's disease."

According to the Alzheimer's Association, more than 5 million Americans are living with the disease. There are an increasing number of new cases diagnosed annually with increasing aging populations. Florida Hospital and VTT's study will utilize the biomarker assay to harness research on Alzheimer's disease and specifically target which types of precautions to take when approaching early stages of the disease.


'/>"/>

Contact: Matej Orešič
matej.oresic@vtt.fi
358-407-055-156
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1

Related biology news :

1. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
2. Warm springs may be best winter refuge for Florida manatees
3. UF researcher describes new 5-million-year-old saber-toothed cat from Florida
4. Stocking Florida bass in Texas reservoirs may alter stream systems connected to stocked reservoirs
5. Scripps Florida scientist awarded prestigious Javits Neuroscience Investigator Award
6. University of Florida reports 2012 US shark attacks highest since 2000
7. Biocontrol research on Brazilian peppertree in Florida discovers new cryptic species
8. Scripps Florida scientists uncover potential drug target to block cell death in Parkinsons disease
9. Pythons, lionfish and now willow invade Floridas waterways
10. $1 million Kenan Trust Grant extends support of Scripps Florida education outreach
11. One click away: Finding data on Floridas endangered species just got easier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation ... and lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland ... AxioMed disc in Bern, Lucerne, and Zurich to discuss the benefits of a ...
(Date:12/2/2016)... OAKS, Calif. , Dec. 2, 2016 Amgen ... AGN ) today announced the submission of a Marketing ... ABP 215, a biosimilar candidate to Avastin ® (bevacizumab). ... application submitted to the EMA. "The submission ... as Amgen seeks to expand our oncology portfolio," said ...
(Date:12/2/2016)... , ... December 01, 2016 , ... ACEA Biosciences, Inc. ... Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, ... an update on the phase I/II clinical trials for AC0010 in patients with advanced ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ... Computational Science Symposium (CSS) and the popularity of US Single Day Events (SDE) ... place in early Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and ...
Breaking Biology Technology: